8,659 Shares in CME Group Inc. (NASDAQ:CME) Purchased by Seven Eight Capital LP

Seven Eight Capital LP acquired a new stake in shares of CME Group Inc. (NASDAQ:CME) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 8,659 shares of the financial services provider’s stock, valued at approximately $1,702,000.

Other hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its holdings in shares of CME Group by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 33,451,194 shares of the financial services provider’s stock valued at $7,044,821,000 after acquiring an additional 215,044 shares in the last quarter. Capital International Investors lifted its position in CME Group by 24.1% in the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares during the period. Capital World Investors boosted its holdings in CME Group by 8.7% in the 4th quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after purchasing an additional 1,172,575 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of CME Group by 2.9% during the 1st quarter. Bank of New York Mellon Corp now owns 6,793,988 shares of the financial services provider’s stock worth $1,462,678,000 after buying an additional 189,842 shares in the last quarter. Finally, Parnassus Investments LLC lifted its holdings in shares of CME Group by 0.4% in the 4th quarter. Parnassus Investments LLC now owns 5,667,384 shares of the financial services provider’s stock valued at $1,193,551,000 after buying an additional 23,583 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

Insider Activity at CME Group

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

CME has been the topic of a number of recent analyst reports. Piper Sandler reaffirmed an “overweight” rating and set a $225.00 price objective on shares of CME Group in a report on Tuesday, August 20th. JPMorgan Chase & Co. increased their price target on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a report on Thursday, August 15th. Barclays upped their target price on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 25th. Finally, Keefe, Bruyette & Woods lifted their price target on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Four analysts have rated the stock with a sell rating, five have issued a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, CME Group currently has an average rating of “Hold” and a consensus target price of $209.73.

CME Group Stock Performance

CME Group stock opened at $216.30 on Thursday. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $223.80. The company has a market capitalization of $77.88 billion, a price-to-earnings ratio of 24.61, a PEG ratio of 8.85 and a beta of 0.55. The stock has a fifty day moving average of $207.08 and a two-hundred day moving average of $207.54. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter last year, the business posted $2.30 EPS. The firm’s quarterly revenue was up 12.7% compared to the same quarter last year. On average, analysts anticipate that CME Group Inc. will post 9.94 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th will be given a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.13%. The ex-dividend date is Monday, September 9th. CME Group’s dividend payout ratio is presently 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.